Replies to post #1128 on BioCurex, Inc.(fka BOCX)

[Headache]

Bocxman, you've mentioned the need for independent validation to move the stock. How will this validation be presented? Is is possible that it could be presented at the ISOBM conference next week? Or will we see it elsewhere, say, in a medical journal or on Abbott's web site?